AU2003240974A1 - Human prolactin antagonist-angiogenesis inhibitor fusion proteins - Google Patents

Human prolactin antagonist-angiogenesis inhibitor fusion proteins

Info

Publication number
AU2003240974A1
AU2003240974A1 AU2003240974A AU2003240974A AU2003240974A1 AU 2003240974 A1 AU2003240974 A1 AU 2003240974A1 AU 2003240974 A AU2003240974 A AU 2003240974A AU 2003240974 A AU2003240974 A AU 2003240974A AU 2003240974 A1 AU2003240974 A1 AU 2003240974A1
Authority
AU
Australia
Prior art keywords
fusion proteins
angiogenesis inhibitor
human prolactin
prolactin antagonist
inhibitor fusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003240974A
Other languages
English (en)
Other versions
AU2003240974A8 (en
Inventor
Wen Yuan Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Greenville Hospital System
Original Assignee
Greenville Hospital System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greenville Hospital System filed Critical Greenville Hospital System
Publication of AU2003240974A8 publication Critical patent/AU2003240974A8/xx
Publication of AU2003240974A1 publication Critical patent/AU2003240974A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57554—Prolactin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AU2003240974A 2002-05-31 2003-06-02 Human prolactin antagonist-angiogenesis inhibitor fusion proteins Abandoned AU2003240974A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38412102P 2002-05-31 2002-05-31
US60/384,121 2002-05-31
PCT/US2003/017216 WO2003102148A2 (en) 2002-05-31 2003-06-02 Human prolactin antagonist-angiogenesis inhibitor fusion proteins

Publications (2)

Publication Number Publication Date
AU2003240974A8 AU2003240974A8 (en) 2003-12-19
AU2003240974A1 true AU2003240974A1 (en) 2003-12-19

Family

ID=29711980

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003240974A Abandoned AU2003240974A1 (en) 2002-05-31 2003-06-02 Human prolactin antagonist-angiogenesis inhibitor fusion proteins

Country Status (6)

Country Link
US (2) US7339027B2 (enExample)
EP (1) EP1513549A4 (enExample)
JP (2) JP4511108B2 (enExample)
AU (1) AU2003240974A1 (enExample)
CA (1) CA2487291A1 (enExample)
WO (1) WO2003102148A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003300904A1 (en) * 2002-12-13 2004-07-09 The Ohio State University Antagonists for human prolactin
US7666583B2 (en) 2004-02-19 2010-02-23 Yale University Identification of cancer protein biomarkers using proteomic techniques
AU2011213758B2 (en) * 2004-02-19 2012-11-15 Yale University Identification of cancer protein biomarkers using proteomic techniques
US7507716B2 (en) * 2005-07-06 2009-03-24 Board Of Regents, The University Of Texas System Method for treating pain with prolactin antagonists
CA2635588C (en) * 2005-12-30 2015-11-10 Dyax Corp. Metalloproteinase binding proteins
WO2009135056A2 (en) * 2008-04-30 2009-11-05 Monsanto Technology Llc Recombinant dna vectors for expression of human prolactin antagonists
WO2013034116A1 (zh) * 2011-09-09 2013-03-14 清华大学 对atp结合位点进行突变的血管内皮抑制素突变体
US10314909B2 (en) 2011-10-21 2019-06-11 Dyax Corp. Combination therapy comprising an MMP-14 binding protein

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2813428B2 (ja) * 1989-08-17 1998-10-22 三菱電機株式会社 電界効果トランジスタ及び該電界効果トランジスタを用いた液晶表示装置
US5315129A (en) * 1990-08-20 1994-05-24 University Of Southern California Organic optoelectronic devices and methods
TW222345B (en) * 1992-02-25 1994-04-11 Semicondustor Energy Res Co Ltd Semiconductor and its manufacturing method
FR2719480B1 (fr) * 1994-05-05 1996-07-26 Agronomique Inst Nat Rech Compositions pharmaceutiques destinées à prévenir et/ou traiter l'expression du comportement de couvaison chez les oiseaux et plus particulièrement chez la dinde et leurs procédés de préparation.
US6278127B1 (en) * 1994-12-09 2001-08-21 Agere Systems Guardian Corp. Article comprising an organic thin film transistor adapted for biasing to form a N-type or a P-type transistor
US5854205A (en) * 1995-10-23 1998-12-29 The Children's Medical Center Corporation Therapeutic antiangiogenic compositions and methods
WO1999016889A1 (en) * 1997-10-01 1999-04-08 G.D. Searle & Co. Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment
EP1070122A4 (en) 1998-03-11 2004-11-10 Univ Texas INDUCTION OF APOPTIC OR CYTOTOXIC GENE EXPRESSION BY ADENOVIRUS-MEDIATED GENE TRANSFER
CN1308347C (zh) * 1999-04-28 2007-04-04 德克萨斯大学董事会 用于通过选择性抑制vegf来治疗癌症的组合物和方法
CA2404088A1 (en) * 2000-03-23 2001-09-27 Greenville Hospital System Bi-functional cancer treatment agents
JP2003000268A (ja) * 2000-08-25 2003-01-07 Pfizer Prod Inc 血管新生にかかわる疾患を診断および治療するための方法および組成物
JP4841751B2 (ja) * 2001-06-01 2011-12-21 株式会社半導体エネルギー研究所 有機半導体装置及びその作製方法
JP4136482B2 (ja) * 2002-06-20 2008-08-20 キヤノン株式会社 有機半導体素子、その製造方法および有機半導体装置
EP1684365A3 (en) * 2005-01-20 2008-08-13 Fuji Electric Holdings Co., Ltd. Transistor

Also Published As

Publication number Publication date
EP1513549A2 (en) 2005-03-16
US20040127407A1 (en) 2004-07-01
EP1513549A4 (en) 2006-05-10
JP4511108B2 (ja) 2010-07-28
JP2010083896A (ja) 2010-04-15
US7339027B2 (en) 2008-03-04
US20090088375A1 (en) 2009-04-02
AU2003240974A8 (en) 2003-12-19
US8304381B2 (en) 2012-11-06
WO2003102148A2 (en) 2003-12-11
JP5221510B2 (ja) 2013-06-26
WO2003102148A3 (en) 2004-07-29
CA2487291A1 (en) 2003-12-11
JP2004002276A (ja) 2004-01-08

Similar Documents

Publication Publication Date Title
IL166751A0 (en) Modified transferin-antibody fusion proteins
AU2003228269A1 (en) Phosphorylated proteins and uses related thereto
AU2003206104A1 (en) Joint prostheses
AU2003266119A1 (en) Artificial joint
AU2003289742A1 (en) Stable therapeutic proteins
AU2003201727A1 (en) Recombinant protein expression
AU2003300904A1 (en) Antagonists for human prolactin
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2003295427A1 (en) Flaviviris fusion inhibitors
AU2003240974A1 (en) Human prolactin antagonist-angiogenesis inhibitor fusion proteins
AU2003260787A1 (en) Protein kinases
EP1576115A3 (en) Protein chips
AU2003282338A1 (en) Determination of protein function
AU2003206519A1 (en) Alpha-HELICAL PROTEIN BASED MATERIALS AND METHODS FOR MAKING SAME
GB0200689D0 (en) Fusion proteins
AU2003238178A1 (en) Pancreas-specific proteins
AU2003252075A1 (en) Human immunosuppressive protein
AU2003213146A1 (en) Activated protein c formulations
AU2003262638A1 (en) Biotinylation of proteins
AU2003202694A1 (en) Torero protein
AU2003280992A1 (en) Novel proteins and use thereof
AU2003220085A1 (en) Protein a compositions and methods of use
AU2003270055A1 (en) Neurotransmission-associated proteins
AU2003276846A1 (en) Thrombopoiesis-stimulating proteins having reduced immunogenicity
AU2003278718A1 (en) Stars-a muscle-specification-binding protein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase